CIK 0001159036
- Large accelerated filer
HALOZYME THERAPEUTICS, INC.
Sign in to watch- Ticker
- HALO
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 880488686
- Phone
- +1 858-794-8889
- Business address
- 12390 EL CAMINO REAL, SAN DIEGO, CA, 92130
- Former names
- HALOZYME THERAPEUTICS INC, GLOBAL YACHT SERVICES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $21,662,139
- in 5 filings, $21.7M under 10b5-1 plans
Net −$21,662,139. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-15 | Torley Helen PRESIDENT AND CEO | Exercise or conversion · Restricted Stock Units | −13,092 | 13,092 | ||
| 2024-02-10 | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | Exercise or conversion | +8,133 | 160,044 | ||
| 2024-02-10 | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | Shares withheld for taxes | −2,901 | $35.49 | $103K | 157,143 |
| 2024-02-10 | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | Exercise or conversion · Restricted Stock Units | −8,133 | 0 | ||
| 2024-02-10 | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | Exercise or conversion | +2,502 | 11,568 | ||
| 2024-02-10 | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | Shares withheld for taxes | −1,477 | $35.49 | $52K | 10,091 |
| 2024-02-10 | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | Exercise or conversion · Restricted Stock Units | −2,502 | 0 | ||
| 2024-02-10 | Torley Helen PRESIDENT AND CEO | Exercise or conversion | +31,281 | 654,947 | ||
| 2024-02-10 | Torley Helen PRESIDENT AND CEO | Shares withheld for taxes | −16,943 | $35.49 | $601K | 638,004 |
| 2024-02-10 | Torley Helen PRESIDENT AND CEO | Exercise or conversion · Restricted Stock Units | −31,281 | 0 | ||
| 2024-01-17 | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | Exercise or conversion 10b5-1 | +10,000 | $12.07 | $121K | 161,911 |
| 2024-01-17 | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | Sale 10b5-1 | −10,000 | $36.00 | $360K | 151,911 |
| 2024-01-17 | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | Exercise or conversion · Option to Purchase Common Stock 10b5-1 | −10,000 | 24,885 | ||
| 2024-01-16 | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | Exercise or conversion 10b5-1 | +10,000 | $12.07 | $121K | 161,911 |
| 2024-01-16 | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | Sale 10b5-1 | −10,000 | $36.00 | $360K | 151,911 |
| 2024-01-16 | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | Exercise or conversion · Option to Purchase Common Stock 10b5-1 | −10,000 | 34,885 | ||
| 2024-01-03 | Snyder Mark Howard SVP, GENERAL COUNSEL | Exercise or conversion | +7,611 | 12,418 | ||
| 2024-01-03 | Snyder Mark Howard SVP, GENERAL COUNSEL | Shares withheld for taxes | −2,957 | $35.78 | $106K | 9,461 |
| 2024-01-03 | Snyder Mark Howard SVP, GENERAL COUNSEL | Exercise or conversion · Restricted Stock Units | −7,611 | 15,222 | ||
| 2023-12-13 | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | Exercise or conversion 10b5-1 | +10,000 | $12.07 | $121K | 161,911 |
Page 34 of 48 · 944 trades